Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05146388 · ClinicalTrials.gov registry record · NA
Working With Doctors and Pharmacists to Help Parents Give Children's Liquid Medicines Safely
A NA study of Medication Dosing Error, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 3
- Study locations
NCT05146388: Recruiting NA study of Medication Dosing Error, sponsored by NYU Langone Health.
NCT05146388 is a NA study of Medication Dosing Error that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 500 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05146388, a NA study of Medication Dosing Error, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 3
- Study locations
Study Summary
The study objective is to assess the impact of an automated electronic health record (EHR)-based intervention that leverages e-prescriptions to support pharmacist adherence to recommended dispensing practices, with the goal of reducing parent dosing errors. Specifically, the study aims are to: 1) Examine the efficacy of the EHR-based intervention in improving pharmacy dispensing practices, including a) adherence to mL-only dosing and b) provision of optimal dosing tools; 2) Examine the efficacy of the EHR-based intervention in reducing parent dosing errors. The study will also explore whether implementation of the EHR-based intervention will reduce disparities in dosing errors by parent health literacy and LEP, and explore the efficacy of the EHR-based intervention in reducing ADEs. A pre-/post-implementation study will be performed with English- and Spanish-speaking parents of children prescribed oral liquid medications in the pediatric emergency room, outpatient general pediatric clinic, and pediatric subspecialty clinics of 2 New York City hospital systems (NYU Langone Health - Brooklyn and NYC Health+Hospitals - Bellevue Hospital). Prior to implementation, e-Rx's will be generated by the EHR in the usual fashion; after implementation, e-Rx's will be generated by the EHR with instructions to the dispensing pharmacy to: 1) keep the dosing instructions in mL-only, and 2) dispense a specific dosing tool based on the amount prescribed. The proposed project is consistent with a growing national focus on promoting the adoption of evidence-based strategies to improve disease management that address the needs of those with low health literacy and LEP from groups like the Joint Commission and the AHRQ.
Primary Outcome
Dosing error will be defined as \>20% deviation from the prescribed dose
Conditions Studied
Interventions
- OTHER EHR-Based Approach
Study Locations (3)
New York
- NYU Langone Health - Brooklyn - Brooklyn
- Sunset Park Family Health Center at NYU Langone - Brooklyn
- NYC Health + Hospitals / Bellevue - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2022-04-21 |
| Est. Completion | 2025-09 |
| Phase | NA |
What NCT05146388 shows while recruiting
NCT05146388 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Medication Dosing Error appearing as the primary indexed condition, and to 1 intervention - of which EHR-Based Approach is the first listed.
NCT05146388 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05146388 about?
NCT05146388 is a clinical study titled "Working With Doctors and Pharmacists to Help Parents Give Children's Liquid Medicines Safely". The study objective is to assess the impact of an automated electronic health record (EHR)-based intervention that leverages e-prescriptions to support pharmacist adherence to recommended dispensing practices, with the goal of reducing parent dosing errors. Specifically, the study aims are to: 1) E...
What is the current status of trial NCT05146388?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2022-04-21. Estimated completion is 2025-09.
What conditions does trial NCT05146388 study?
This clinical trial studies the following conditions: Medication Dosing Error.
What interventions are being tested in trial NCT05146388?
The interventions under investigation include: EHR-Based Approach (OTHER).
Who is sponsoring clinical trial NCT05146388?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05146388 being conducted?
This trial has 3 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05146388's enrollment target sits among peer trials
500 193rd of 2000 higher than 1,788 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI